ADVERTISEMENT

Sun Pharma Q2 Results Review - Inline Operational Performance: Nirmal Bang

Revenue grew by ~11% YoY on the back of growth across major geographies and ramp-up in the global specialty portfolio.

<div class="paragraphs"><p>Sun Pharmaceutical Industries Ltd.'s HQ in Mumbai. (Source: Wiki)</p></div>
Sun Pharmaceutical Industries Ltd.'s HQ in Mumbai. (Source: Wiki)
BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit